Collegium enters $25M accelerated share repurchase; 692,281 shares initially delivered

COLLEGIUM PHARMACEUTICAL, INC

ASR with Jefferies for $25M; part of $150M repurchase program authorized Jan 2024.
Initial delivery of 692,281 shares (approx 80% of expected) at $28.89 closing price on May 9.
Final settlement expected by Q3 2025; shares based on volume-weighted average price.
As of March 31, 2025, Collegium had ~32.1M shares outstanding.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.